Re: LISONOPRIL I More common side effects blurred

New Post Public Reply Private Reply Replies (2) Message Board
copytele SaltyMutt #126883
165

Re: LISONOPRIL
I

More common side effects
blurred vision
cloudy urine
confusion
decrease in urine output or decrease in urine-concentrating ability
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
sweating
unusual tiredness or weakness
Less common side effects
abdominal or stomach pain
body aches or pain
chest pain
chills
common cold
cough
diarrhea
difficulty breathing
ear congestion
fever
headache
loss of voice
nasal congestion
nausea
runny nose
sneezing
sore throat
vomiting
Rare side effects
arm, back, or jaw pain
chest discomfort, tightness, or heaviness
fast or irregular heartbeat
general feeling of discomfort or illness
joint pain
loss of appetite
muscle aches and pains
shivering
trouble sleeping
Other side effects of lisinopril
Some side effects of lisinopril may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common side effects
decreased interest in sexual intercourse
inability to have or keep an erection
lack or loss of strength
loss in sexual ability, desire, drive, or performance
rash
Rare side effects
acid or sour stomach
belching
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
feeling of constant movement of self or surroundings
heartburn
indigestion
muscle cramps
sensation of spinning
stomach discomfort or upset
swelling
Managing side effects (general information)
For healthcare professionals
Applies to lisinopril: oral solution, oral tablet.

Cardiovascular adverse events
Very common (10% or more): Hypotension (11%)
Common (1% to 10%): Chest pain, angina pectoris, orthostatic hypotension, palpitations
Uncommon (0.1% to 1%): Angioneurotic edema, myocardial infarction or cerebrovascular accident, palpitations, tachycardia, Raynaud's phenomenon[Ref]
Hypotension is most likely in patients who are sodium and intravascular volume depleted. In large studies, patients have reported "heart pounding" and chest pain, although the relationship to lisinopril is questionable.[Ref]

Renal
Common (1% to 10%): Creatinine increased (10%)
Very rare (less than 0.01%): Renal insufficiency[Ref]
Nervous system
Very common (10% or more): Dizziness (19%)
Common (1% to 10%): Headache, syncope
Uncommon (0.1% to 1%): Paresthesias[Ref]
Respiratory
Common (1% to 10%): Creatinine increased (10%)
Uncommon (0.1% to 1%): Rhinitis
Very rare (less than 0.01%): Bronchospasm, sinusitis, allergic alveolitis/eosinophilic pneumonia[Ref]
A study has revealed a significantly higher incidence of discontinuation of angiotensin converting enzyme inhibitor therapy due to cough among black patients compared with nonblack patients (9.6% vs. 2.4%).[Ref]

Metabolic
Common (1% to 10%): Hyperkalemia
Frequency not reported: Gout, hypoglycemia in diabetic patients receiving ACE inhibitors when concurrently treated with oral antidiabetic agents or insulin[Ref]
Gastrointestinal
Common (1% to 10%): Diarrhea, nausea, vomiting
Frequency not reported: Pancreatitis, constipation, flatulence, dry mouth, taste disturbance[Ref]
Hypersensitivity
Uncommon (0.1% to 1%): Angioedema[Ref]
Dermatologic
Uncommon (0.1% to 1%): Rash, pruritus, erythema
Rare (0.01% to 0.1%): Alopecia, urticaria, psoriasis, hypersensitivity/angioedema, angioneurotic edema of the face, extremities, lips, tongue, glottis, and/or larynx
Very rare (less than 0.01%): Sweating, skin lesions, skin infections, pemphigus, toxic epidermal necrolysis, Stevens-Johnson Syndrome, erythema multiforme, cutaneous pseudolymphoma
Frequency not reported: Photosensitivity, flushing, diaphoresis[Ref]
Hematologic
Very rare (less than 0.01%): Bone marrow depression, hemolytic anemia, leukopenia/neutropenia, thrombocytopenia, decreases in hemoglobin, decreases in hematocrit[Ref]
Psychiatric
Rare (0.01% to 0.1%): Memory impairment, confusion, somnolence, irritability, nervousness, hallucinations
Very rare (less than 0.01%): Mania
Hepatic
Common (1% to 10%): Creatinine increased
Very rare (less than 0.01%): Cholestatic jaundice that progresses to fulminant hepatic necrosis and sometimes death (discontinue of therapy if jaundice or markedly elevated hepatic serum enzymes develop)
Endocrine
Very rare (less than 0.01%): Diabetes, syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Other
Common (1% to 10%): Cough
Frequency not reported: Fatigue, asthenia, orthostatic effects, tinnitus, olfactory disturbance
Genitourinary
Uncommon (0.1% to 1%): Impotence
Rare (less than 0.1%): Gynecomastia
Frequency not reported: Proteinuria
See also:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Senior Care Location Opens in Broward County

Updated Category News Views 197

A Personal Mission Driving Business in Hollywood Dive deep into any community, and you'll often find stories that tug at the heartstrings—especially when they're about family. That's the case with Saudia Sital, a Broward County local who's just opened Always Best Care Senior Services in Hollywood, Florida. Her journey from personal caregiver to business owner isn't just...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 117

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Matthew Callstrom Named CEO: Mayo Clinic's Next Era

Updated Category News Views 129

Leadership Change at Mayo Clinic: A Turning Point The Mayo Clinic, a titan in healthcare lands, is on the cusp of a major leadership switch-up. As the trustees hand the reins to Dr. Matthew R. Callstrom, they're banking on a rich blend of experience and visionary thinking to steer their ship. We're looking at what this change might spell for Mayo's storied mission. Who is...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 65

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 106

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 162

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 81

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
TagMaster To Acquire Kapsch's RFID Ops in NA Market

Updated Category News Views 144

A Strategic Move in the Transportation Sector Here's a fresh shake-up for the North American transportation sector: TagMaster, alongside its U.S. subsidiary Sensys Networks, is all set to acquire Kapsch TrafficCom's RFID-focused North American components business. This isn't just a minor shuffle—this deal could ripple through the industry, promising strategic uplifts...

Continue Reading
Lavazza 2027 Calendar: Moments of Pleasure Worldwide

Updated Category News Views 248

Capturing Fleeting Joy Through the Lens In 2027, Lavazza sets the stage for an evocative exploration of human pleasure through its iconic calendar. Teaming up with photographers Jim Goldberg, Alex Majoli, and Paolo Pellegrin, the project spans three vibrant cities: New York, Lisbon, and Hong Kong. These masters of the lens invite us to pause and appreciate the understated...

Continue Reading
TruGreen Finds New Growth in Birch Hill Acquisition

Updated Category News Views 186

TruGreen's New Chapter Begins In the world of lawn care, TruGreen is sowing the seeds for a revitalized future, courtesy of its recent acquisition by Birch Hill Equity Partners. Based out of Franklin, Tennessee, this powerhouse in the green arena is set to start a fresh chapter, swapping partners like old gloves after a long, 19-year stint with Clayton, Dubilier & Rice...

Continue Reading

Top 5 Most Recently Viewed Articles

David Lord Steps In as New CEO of WorkforceQA, Eric Quilter Moves Up

Updated Category News Views 658

David Lord Takes the Helm as WorkforceQA's New CEO WorkforceQA is excited to welcome David Lord as its new Chief Executive Officer. With a strong history of leadership and a substantial track record of driving growth, David is set to guide the company in providing top-tier compliance and screening solutions. Transition of Leadership In this significant shift, current CEO...

Continue Reading
VARON Champions Environmental Sustainability with Innovative Solutions

Updated Category News Views 323

VARON Champions Environmental Sustainability in Respiratory Care This Earth Day, VARON is proudly reinforcing its commitment to respiratory health and environmental responsibility. As a renowned leader in oxygen concentrator technology, the company remains dedicated to promoting sustainable innovation by offering eco-friendly alternatives to traditional oxygen delivery...

Continue Reading
Revolutionizing AIoT: Hikvision's Launch of Guanlan Models

Updated Category News Views 369

Innovative Launch of Guanlan Large-Scale AI Models Hikvision has officially unveiled its latest advancement in technology with the introduction of Guanlan Large-Scale AI Models. This suite of sophisticated machine learning engines has been meticulously pre-trained using extensive industry knowledge, allowing them to excel across various domains such as computer vision,...

Continue Reading
EssilorLuxottica's Record Shareholding Milestones Showcase Growth

Updated Category News Views 247

EssilorLuxottica’s Remarkable Growth in Employee Shareholding EssilorLuxottica, a global leader in eyewear and optical solutions, is experiencing significant growth, particularly in its employee shareholding initiatives. With nearly 100,000 internal shareholders spread across 85 countries, the company is witnessing an unprecedented level of engagement and investment...

Continue Reading
Exploring the Growth of the Global Medical Equipment Maintenance Market

Updated Category News Views 440

Understanding the Medical Equipment Maintenance Market The medical equipment maintenance market is poised for remarkable growth in the upcoming years. Experts forecast that this market is expected to witness a significant increase, estimated at USD 51.2 billion between 2024 and 2028. This growth reflects a compound annual growth rate (CAGR) of 13.64%, showcasing an...

Continue Reading